A Follow-up Study with a Double-blinded, Randomized Controlled Vitamin D Supplementation Trial in Patients with Major Depressive Episode (DepFuD): A Study Protocol and Baseline Characteristics

Overview

Journal Food Sci Nutr

Specialty Biotechnology

Date 2024 Oct 31

PMID 39479665

Authors

T Mikola

S M Lehto

K Honkalampi

M Valkonen-Korhonen

H Koivumaa-Honkanen

T Tolmunen

V Laukkanen

M Pakarinen

A Ruusunen

Affiliations

Soon will be listed here.

Abstract

Promising initial studies on vitamin D (VD) supplementation as an adjunct treatment for major depressive disorder (MDD) require rigorously designed randomized controlled trials (RCTs). We aim to investigate the effects of augmenting standard MDD treatment with VD supplementation and examine factors influencing the treatment outcome. This article describes the study design, measures, and baseline characteristics. This multicenter RCT compares the efficacy of a six-month VD intervention at 100 micrograms/day versus 10 micrograms/day (μg/day) (4000 IU (international units)/day vs. 400 IU/day) added to a standard treatment in outpatients aged 20-61 years with MDD. The primary outcome is change in the Montgomery-Åsberg Depression Rating Scale (MADRS) score. Secondary outcomes are other indicators of mental health and functionality (BDI, SOC, 15-D, PSS10, LS-4, LOT-R, YSQ-S2-extended, CORE-OM, TAS-20, BRCS, TADS, SCL-90, DIAD, GAF), and circulating biomarkers. Intervention assessments are conducted at baseline, 3, and 6 months, and follow-ups at 18 months and 6 years post-baseline. The baseline sample had 319 subjects (74% women; median age 31 (inter-quartile range (IQR) 15), mean MADRS score 21.38 (SD 6.04)), with 281 assigned to the RCT. At present, the study continues as a follow-up study. DepFuD project will provide extensive information regarding the potential benefits of VD and enables to identify various biopsychosocial depression-associated risk factors.

References

Chiesi F, Galli S, Primi C, Innocenti Borgi P, Bonacchi A . The accuracy of the Life Orientation Test-Revised (LOT-R) in measuring dispositional optimism: evidence from item response theory analyses. J Pers Assess. 2013; 95(5):523-9. DOI: 10.1080/00223891.2013.781029. View

Aalto A, Elovainio M, Kivimaki M, Uutela A, Pirkola S . The Beck Depression Inventory and General Health Questionnaire as measures of depression in the general population: a validation study using the Composite International Diagnostic Interview as the gold standard. Psychiatry Res. 2012; 197(1-2):163-71. DOI: 10.1016/j.psychres.2011.09.008. View

Scheier M, Carver C, Bridges M . Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol. 1994; 67(6):1063-78. DOI: 10.1037//0022-3514.67.6.1063. View

Lam R, Kennedy S, Adams C, Bahji A, Beaulieu S, Bhat V . Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des.... Can J Psychiatry. 2024; 69(9):641-687. PMC: 11351064. DOI: 10.1177/07067437241245384. View

Honkalampi K, Laitila A, Juntunen H, Lehmus K, Piiparinen A, Tormanen I . The Finnish Clinical Outcome in Routine Evaluation Outcome Measure: psychometric exploration in clinical and non-clinical samples. Nord J Psychiatry. 2017; 71(8):589-597. DOI: 10.1080/08039488.2017.1365378. View

Saariaho T, Saariaho A, Karila I, Joukamaa M . The psychometric properties of the Finnish Young Schema Questionnaire in chronic pain patients and a non-clinical sample. J Behav Ther Exp Psychiatry. 2008; 40(1):158-68. DOI: 10.1016/j.jbtep.2008.07.005. View

Opie R, Itsiopoulos C, Parletta N, Sanchez-Villegas A, Akbaraly T, Ruusunen A . Dietary recommendations for the prevention of depression. Nutr Neurosci. 2015; 20(3):161-171. DOI: 10.1179/1476830515Y.0000000043. View

Giollabhui N, Ng T, Ellman L, Alloy L . The longitudinal associations of inflammatory biomarkers and depression revisited: systematic review, meta-analysis, and meta-regression. Mol Psychiatry. 2020; 26(7):3302-3314. PMC: 7887136. DOI: 10.1038/s41380-020-00867-4. View

Koivumaa-Honkanen H, Rissanen T, Hintikka J, Honkalampi K, Haatainen K, Tarja S . Factors associated with life satisfaction in a 6-year follow-up of depressive out-patients. Soc Psychiatry Psychiatr Epidemiol. 2010; 46(7):595-605. DOI: 10.1007/s00127-010-0225-z. View

10.

Yang H, Gao S, Li J, Yu H, Xu J, Lin C . Remission of symptoms is not equal to functional recovery: Psychosocial functioning impairment in major depression. Front Psychiatry. 2022; 13:915689. PMC: 9360322. DOI: 10.3389/fpsyt.2022.915689. View

11.

Lopresti A, Hood S, Drummond P . A review of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep and exercise. J Affect Disord. 2013; 148(1):12-27. DOI: 10.1016/j.jad.2013.01.014. View

12.

Cheng Y, Huang Y, Huang W . The effect of vitamin D supplement on negative emotions: A systematic review and meta-analysis. Depress Anxiety. 2020; 37(6):549-564. DOI: 10.1002/da.23025. View

13.

Beck A, Ward C, Mendelson M, Mock J, ERBAUGH J . An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4:561-71. DOI: 10.1001/archpsyc.1961.01710120031004. View

14.

Malhi G, Mann J . Depression. Lancet. 2018; 392(10161):2299-2312. DOI: 10.1016/S0140-6736(18)31948-2. View

15.

ANTONOVSKY A . The structure and properties of the sense of coherence scale. Soc Sci Med. 1993; 36(6):725-33. DOI: 10.1016/0277-9536(93)90033-z. View

16.

Turck D, Bresson J, Burlingame B, Dean T, Fairweather-Tait S, Heinonen M . Dietary reference values for vitamin K. EFSA J. 2020; 15(5):e04780. PMC: 7010012. DOI: 10.2903/j.efsa.2017.4780. View

17.

Joukamaa M, Miettunen J, Kokkonen P, Koskinen M, Julkunen J, Kauhanen J . Psychometric properties of the Finnish 20-item Toronto Alexithymia Scale. Nord J Psychiatry. 2002; 55(2):123-7. DOI: 10.1080/08039480151108561. View

18.

Marx W, Lane M, Hockey M, Aslam H, Berk M, Walder K . Diet and depression: exploring the biological mechanisms of action. Mol Psychiatry. 2020; 26(1):134-150. DOI: 10.1038/s41380-020-00925-x. View

19.

Mikola T, Marx W, Lane M, Hockey M, Loughman A, Rajapolvi S . The effect of vitamin D supplementation on depressive symptoms in adults: A systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2022; 63(33):11784-11801. DOI: 10.1080/10408398.2022.2096560. View

20.

Willner P, Scheel-Kruger J, Belzung C . The neurobiology of depression and antidepressant action. Neurosci Biobehav Rev. 2012; 37(10 Pt 1):2331-71. DOI: 10.1016/j.neubiorev.2012.12.007. View